Gerry Byrne at the Industry, Science and Technology Committee

What I'm looking for is whether or not it would be helpful, in terms of completing the regulatory environment, from Health Canada's point of view, from the patent office point of view, from CIDA's point of view, and from Industry Canada's point of view.